Skip to content
10-K/A

Annual Report

Faeth Therapeutics, Inc. FTH SNSE

0001193125-26-252637

← back to feed
Filed
Jun 2, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 23, 2026 1.34M sh